Stephen Clark Purchases 5,260 Shares of Amrize (NYSE:AMRZ) Stock

Amrize Ltd (NYSE:AMRZGet Free Report) insider Stephen Clark bought 5,260 shares of Amrize stock in a transaction dated Tuesday, August 11th. The stock was acquired at an average price of $47.31 per share, for a total transaction of $248,850.60. Following the completion of the acquisition, the insider owned 10,637 shares in the company, valued at approximately $503,236.47. The trade was a 97.82% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Amrize Stock Down 0.2%

Shares of NYSE AMRZ opened at $46.66 on Friday. The firm’s 50-day moving average price is $51.21 and its 200-day moving average price is $54.47. The company has a current ratio of 1.10, a quick ratio of 0.89 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $25.81 billion, a price-to-earnings ratio of 21.50, a P/E/G ratio of 1.00 and a beta of 0.11. Amrize Ltd has a 12-month low of $46.03 and a 12-month high of $65.94.

Amrize (NYSE:AMRZGet Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a return on equity of 10.22% and a net margin of 9.89%.The company had revenue of $3.50 billion during the quarter. On average, equities research analysts anticipate that Amrize Ltd will post 2.72 EPS for the current fiscal year.

Amrize Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th will be paid a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, August 18th. Amrize’s dividend payout ratio (DPR) is presently 20.28%.

Trending Headlines about Amrize

Here are the key news stories impacting Amrize this week:

  • Positive Sentiment: Multiple insiders bought shares: Executives purchased more than $697,000 of Amrize stock on August 11, including CFO Baris Oran, CTO Roald Brouwer, Stephen S. Clark, Mario Gross and Jaime Hill. The buying may signal that management considers the recent weakness an attractive entry point. Amrize insider buying report
  • Positive Sentiment: Stephens maintained a Buy rating on Amrize, reinforcing the view that the building-materials company has longer-term upside potential. Stephens maintains Buy rating
  • Positive Sentiment: Amrize declared a quarterly dividend of $0.11 per share, payable August 26 to shareholders of record August 18. The dividend provides modest income support, although the ex-dividend date may contribute to near-term trading volatility.
  • Neutral Sentiment: Jefferies initiated coverage with a Hold rating, giving investors a cautious view that offsets some of the optimism from Stephens and the insider purchases. Jefferies gives Amrize a Hold rating
  • Negative Sentiment: Amrize’s latest quarterly earnings missed expectations, with EPS of $0.88 versus the $0.92 consensus estimate. Revenue was $3.50 billion, while analysts expect full-year EPS of $2.72, keeping earnings execution a concern.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. MCF Advisors LLC purchased a new stake in shares of Amrize in the 4th quarter worth $27,000. Basepoint Wealth LLC purchased a new position in shares of Amrize during the fourth quarter valued at $33,000. Laurel Wealth Advisors LLC bought a new stake in shares of Amrize in the fourth quarter valued at about $34,000. US Bancorp DE purchased a new stake in Amrize in the third quarter worth about $38,000. Finally, Itau Unibanco Holding S.A. grew its holdings in Amrize by 150.0% during the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock worth $41,000 after acquiring an additional 450 shares in the last quarter.

Analysts Set New Price Targets

AMRZ has been the topic of several analyst reports. Royal Bank Of Canada downgraded Amrize from a “sector perform” rating to an “underperform” rating and cut their target price for the company from $60.00 to $48.00 in a research report on Monday. Morgan Stanley set a $63.00 price target on Amrize and gave the stock an “overweight” rating in a research report on Monday, June 22nd. Citigroup dropped their price objective on shares of Amrize from $66.00 to $58.00 and set a “buy” rating for the company in a research note on Tuesday. Vertical Research raised shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective for the company in a research note on Friday, May 1st. Finally, Oppenheimer cut their price objective on shares of Amrize from $68.00 to $65.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 21st. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $60.57.

Get Our Latest Stock Report on Amrize

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Articles

Insider Buying and Selling by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.